TD Cowen Reiterates Buy Rating on Regeneron Pharma (REGN)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| Regeneron (NASDAQ: REGN) | Delayed: 746.54 +6.97 (0.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $739.57 | 52 Week High | $592.36 | |||
| Open | $737.20 | 52 Week Low | $325.35 | |||
| Day High | $751.27 | P/E | 195.94 | |||
| Day Low | $732.83 | EPS | $3.81 | |||
| Volume | 466,020 | |||||
